Xcell Therapeutics Inc. (KOSDAQ:373110)
South Korea · Delayed Price · Currency is KRW 1,597.00
+368.00 (29.94%)
May 21, 2026, 10:46 AM KST
Xcell Therapeutics Market Cap
Xcell Therapeutics has a market cap or net worth of 21.25 billion as of May 20, 2026. Its market cap has decreased by -49.40% in one year.
Market Cap
21.25B
Enterprise Value
19.84B
Revenue
1.95B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,597.00
Market Cap Chart
Since July 15, 2024, Xcell Therapeutics's market cap has decreased from 90.22B to 21.25B, a decrease of -76.44%. That is a compound annual growth rate of -54.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 20, 2026 | 21.25B | -26.01% |
| Dec 30, 2025 | 28.73B | -35.28% |
| Dec 30, 2024 | 44.38B | -50.80% |
| Jul 15, 2024 | 90.22B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vaxcell-Bio Therapeutics | 145.59B |
| MedPacto | 144.30B |
| ENCell | 130.59B |
| Amicogen | 120.26B |
| iNtRON Biotechnology | 97.53B |
| GeneOne Life Science | 95.30B |
| Prestige BioPharma | 90.63B |
| CG Invites | 87.27B |